The Role of Competitive Intelligence in Biopharma - Developing Market Access Strategies
Monday, 23rd February 2015
Yulia Aspinall considers the role of competitive intelligence in developing and marketing new drugs, and how information from FreePint can help information professionals harvest intelligence from sources such as specialist drug development databases, news platforms and knowledge software.
It can take over 10 years and around $1 billion to develop a single new drug from its discovery in the lab to it being available for the treatment of patients. A key challenge for any biopharmaceutical company is therefore how to develop and market a drug which produces revenue that exceeds the research and development (R&D) cost.
To market a new drug two important decisions have to be reached:
- Market authorisation
- Obtaining reimbursement or coverage.
Market authorisation can be obtained by convincing regulatory agencies like the European Medicine Agency (EMA) in Europe and the Food and Drug Administration (FDA) in the US about the efficacy and safety of the drug. However, in order to ensure market uptake, a "value for money" assessment is increasingly being demanded by cash-strapped healthcare systems.
The market access strategy provided is generally specific for each market assessment. This process requires comparative market analysis, and a large number of market characteristics have to be taken into consideration, including current therapy standards, expected number of target patients, price and more.
CI to Support Market Access Strategies
Competitive intelligence (CI), as a process of gathering, analysing and interpreting internal and external information and intelligence on competitors and the competitive environment, can undoubtedly support the requirement of those who develop market access strategies.
Relevant to market access, comparative information and intelligence which is routinely collected and analysed by CI professionals, could be divided into four pillars:
- Drug attributes (efficacy, safety, etc)
- Drug development process (MOA, clinical trials, patents, etc)
- Market and treatment (epidemiology, unmet needs, patients, etc)
- Price, reimbursement, promotion (comparator price, clinical benefits, pricing models, payers, etc)
Figure 1: Information requirements for market access
Updates and Reviews from FreePint
FreePint often provides updates and reviews of information resources for competitive intelligence professionals, which can be also be used for harvesting and analysis of relevant market access information.
- One such resource is Cortellis, which draws on well-known databases such as Thomson Pharma and IDRAC to offer a wealth of information across the entire drug development cycle. Here, users can find information on drugs, patents, epidemiology, scientific literature, pricing, regulatory documents and more. The ability of Cortellis technology to provide comparative analysis of different types of information is of particular relevance to market access professionals.
- AdisInsight's new platform brings together three drug information databases: Clinical Trials Insight, R&D Insight, and Pharmacovigilance Insight.
- PharmaCircle also provides both information and analysis on all aspects of the research-based and generic biopharmaceutical business with global coverage of research, development, regulatory, clinical, and business activities. Currently PharmaCircle includes 40 integrated databases (modules) providing a detailed analysis of drug delivery technologies, clinical trials, regulatory documents, marketed products, pipelines, deals, acquisitions, and supply chain details.
- Analysis of various news resources helps to identify the relevant one to monitor biopharmaceutical markets in different countries, whilst articles on information analysis and visualisation tools can also assist with finding the right software to integrate and analyse vast amounts of information.
- Finally, recent detailed reviews on knowledge and information management software, such as Intelligence Plaza, Comintelli and Digimind, can provide a good starting point for the sharing tools implementation, which can reduce duplication and save cost in information research, database purchasing and third party support.
- Blog post title: The Role of Competitive Intelligence in Biopharma - Developing Market Access Strategies
- Link to this page
- View printable version
- Product Review of AdisInsight (Introduction; Contact Details)
Tuesday, 3rd February 2015
- Product Review of Intelligence Plaza (Sources - Content & Coverage)
Thursday, 8th January 2015
- Product Review of PharmaCircle: Value, Development, Help & Pricing
Wednesday, 26th March 2014
- Product Review of Digimind Social: Sources, Content, Analysis & Display Options
Wednesday, 19th February 2014
- Subscription Update for Pharmaceutical Companies
Monday, 26th January 2015
- Niche Data Visualisation Tools - FreePint for Biopharma
Friday, 21st November 2014
- FreePint Report: News, and Beyond
Thursday, 29th January 2015
- FreePint Report: Product Review of Cortellis
Tuesday, 22nd July 2014
- FreePint Report: Product Review of Comintelli Knowledge XChanger
Sunday, 6th July 2014
Improve your negotiation position, measure performance of your portfolio of external content, and communicate more effectively with stakeholders.
A Jinfo Subscription gets you access to activity-based content to move your projects forward, plus dynamic peer group discussions on meaty topics.
- Enhancements to the Jinfo website
Thursday, 21st January 2021
- Research update - what matters most to smart information managers
Thursday, 21st January 2021
- Research update - what's your focus in 2021?
Thursday, 7th January 2021
- Mini review of M-Brain's Intelligence Plaza
Monday, 18th January 2021
- Product review of Aurora FirstLight (value - purchasing, development and competitor landscape)
Thursday, 14th January 2021
- Product review of Aurora FirstLight (technology - search & user interface; outputs & alerts; administration)
Wednesday, 13th January 2021
- Product review of Aurora FirstLight
Monday, 11th January 2021
- Market landscape - patent products
Monday, 21st December 2020
- Product review of TRG Screen's Quest
Friday, 18th December 2020
- Negotiation clinic - role-play and Q&A (Community) Tuesday, 13th April 2021
- Usage data in contract negotiations (Community) Tuesday, 23rd March 2021
- Pricing models for information and data licensing (Community) Tuesday, 2nd March 2021
- Comparative product evaluation - breaking it down into manageable pieces (Webinar) Tuesday, 19th January 2021
- The importance of current awareness tracking (Webinar) Tuesday, 12th January 2021
- State of the Industry, 2021 (Webinar) Tuesday, 5th January 2021
Our proven processes, resources and guidance will help your team make the shift from transaction centre to strategic asset.
Designed around the most common challenges and pain points for time- and resource-strapped information teams
A tailored overview of our research and active discussion with your Jinfo analyst.
Measure your starting point to articulate your strengths and set priorities for future improvements. Assessments gauge risk, capacity, value and more.
Read case studies, and start the conversation: